Cancer therapy, whether it be radiation, chemotherapy, immunotherapy or targeted therapy, has improved patient survival rates and increased the overall cure rate. These treatments have made tremendous leaps and bounds in the quest to cure cancer, but they are not without their complications. They can sometimes cause problems in the heart and vascular system - called cardiotoxicity. Cardiac side effects can develop before or after cancer treatment, and can cause long-term heart damage and can often be fatal.

The cardio-oncology team treats patients who are at high risk for heart complications as well as those who have a history of heart disease. Utilizing a collaborative approach to personalized care, our expert team reduces and manages the risks of treatment-related cardiac toxicities.

Why choose SSMC?


At SSMC, our multidisciplinary team of doctors, nurses, and healthcare professionals are fully equipped to assess and manage cardiovascular conditions associated with every stage of cancer and its treatment. Our comprehensive services include monitoring and treating heart-related complications such as cardiotoxicity, heart failure, arrhythmias, and hypertension, all of which that can arise during or after cancer therapy. We specialize in preventive care to minimize cardiac risks before starting cancer treatment, as well as ongoing cardiac support throughout a patient’s cancer journey. Our team consists of Western board-certified physicians who are leading experts in cardio-oncology, utilize the latest technology and research-driven practices to provide high-quality care. Dedicated to ensuring a comfortable and supportive experience for all our patients, SSMC is always at the forefront of emphasizing compassionate, personalized care.
  • Cardiac MRI
  • Electrophysiology
  • Coronary angiogram
  • ECG and holter monitoring

Symptoms and diagnosis

Any cancer therapy that affects cardiac safety requires precise monitoring. Cancer complications include:
  • Arrhythmias and QT prolongation
  • Cardiomyopathy and heart failure
  • Hypertension
  • Myocarditis
  • Venous and arterial thrombosis
Patients, who experience symptoms associated with these cardiovascular complications during cancer therapy, undergo early investigation and diagnosis. This may include:
  • Ambulatory blood pressure monitoring
  • Biomarkers and blood tests
  • Cardiac computerized tomography (CT) coronary angiogram including pulmonary embolism protocol
  • Cardiac MRI
  • Comprehensive echocardiography including global longitudinal strain assessment
  • Coronary angiogram
  • Duplex arterial or venous for periphery
  • ECG and holter monitoring
  • Endomyocardial biopsy
  • Nuclear scintigraphy
  • Vital signs test

Treatments

Treatment for cardiac complications caused by cancer therapies can be prevented via:
  • Antiarrhythmics
  • Anticoagulation
  • Diuretics
  • Heart failure drugs
  • Heart failure therapy
  • Hypertension therapy
  • Surgery (in rare cases)
Additionally, we evaluate, diagnose and treat cardiac toxicities related to cancer treatments, and use the process of risk stratification to minimize the risk of cardiovascular complications, which involves identifying the right level of care and services for distinct subgroups of patients. Moreover, we:
  • Consider cardiovascular risk factors prior to cancer therapy
  • Ensure early detection of cardiovascular complications
  • Provide the early therapy of complications
  • Prevent cardiac complications during and post cancer therapy
  • Endoscopy
  • Colonoscopy using artificial intelligence
  • Intragastric balloons
  • Endoscopic sleeve gastroplasty

Meet our team

Powered by Ajaxy